| Mr Robert Jordan Lakko, DO | |
|
1090 W Park Pl, Coeur D Alene, ID 83814-2785 | |
| (208) 292-0292 | |
| Not Available |
| Full Name | Mr Robert Jordan Lakko |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 1090 W Park Pl, Coeur D Alene, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174756340 | NPI | - | NPPES |
| O-0886 | Other | ID | ID STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20300 (Montana) | Secondary |
| 207Q00000X | Family Medicine | O-0886 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loving Care And More | Silverton, ID | Home health agency |
| Shoshone Medical Center | Kellogg, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shoshone Medical Center | 6103739107 | 6 |
| Coeur D Alene Primary Care Pllc | 8729216171 | 3 |
News Archive
Central venous catheters are commonly used to provide permanent hemodialysis for patients with serious kidney disease.
The new Randox Acusera multi-analyte Liquid Tumour Marker Control covers a total of 15 commonly tested and esoteric cancer antigens and tumour markers. The addition of assayed target values enables laboratories to effectively monitor both accuracy and precision.
Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.
A new Kaiser Permanente study found that the risk of younger siblings developing an autism spectrum disorder is 14 times higher if an older sibling has ASD. The study, which was published today in Journal of Developmental & Behavioral Pediatrics, also found the risk level was consistent across gestational age at birth.
› Verified 4 days ago
| Entity Name | Shoshone Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043215437 PECOS PAC ID: 6103739107 Enrollment ID: O20050113001084 |
News Archive
Central venous catheters are commonly used to provide permanent hemodialysis for patients with serious kidney disease.
The new Randox Acusera multi-analyte Liquid Tumour Marker Control covers a total of 15 commonly tested and esoteric cancer antigens and tumour markers. The addition of assayed target values enables laboratories to effectively monitor both accuracy and precision.
Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.
A new Kaiser Permanente study found that the risk of younger siblings developing an autism spectrum disorder is 14 times higher if an older sibling has ASD. The study, which was published today in Journal of Developmental & Behavioral Pediatrics, also found the risk level was consistent across gestational age at birth.
› Verified 4 days ago
| Entity Name | North Idaho Day Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104824739 PECOS PAC ID: 0840101218 Enrollment ID: O20110401000539 |
News Archive
Central venous catheters are commonly used to provide permanent hemodialysis for patients with serious kidney disease.
The new Randox Acusera multi-analyte Liquid Tumour Marker Control covers a total of 15 commonly tested and esoteric cancer antigens and tumour markers. The addition of assayed target values enables laboratories to effectively monitor both accuracy and precision.
Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.
A new Kaiser Permanente study found that the risk of younger siblings developing an autism spectrum disorder is 14 times higher if an older sibling has ASD. The study, which was published today in Journal of Developmental & Behavioral Pediatrics, also found the risk level was consistent across gestational age at birth.
› Verified 4 days ago
| Entity Name | Coeur D Alene Primary Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922431360 PECOS PAC ID: 8729216171 Enrollment ID: O20140111000034 |
News Archive
Central venous catheters are commonly used to provide permanent hemodialysis for patients with serious kidney disease.
The new Randox Acusera multi-analyte Liquid Tumour Marker Control covers a total of 15 commonly tested and esoteric cancer antigens and tumour markers. The addition of assayed target values enables laboratories to effectively monitor both accuracy and precision.
Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.
A new Kaiser Permanente study found that the risk of younger siblings developing an autism spectrum disorder is 14 times higher if an older sibling has ASD. The study, which was published today in Journal of Developmental & Behavioral Pediatrics, also found the risk level was consistent across gestational age at birth.
› Verified 4 days ago
| Entity Name | Vibra Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659705424 PECOS PAC ID: 8921233933 Enrollment ID: O20141105002107 |
News Archive
Central venous catheters are commonly used to provide permanent hemodialysis for patients with serious kidney disease.
The new Randox Acusera multi-analyte Liquid Tumour Marker Control covers a total of 15 commonly tested and esoteric cancer antigens and tumour markers. The addition of assayed target values enables laboratories to effectively monitor both accuracy and precision.
Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.
A new Kaiser Permanente study found that the risk of younger siblings developing an autism spectrum disorder is 14 times higher if an older sibling has ASD. The study, which was published today in Journal of Developmental & Behavioral Pediatrics, also found the risk level was consistent across gestational age at birth.
› Verified 4 days ago
| Entity Name | Utah Regional Hospitalists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740715507 PECOS PAC ID: 4789807165 Enrollment ID: O20170811001682 |
News Archive
Central venous catheters are commonly used to provide permanent hemodialysis for patients with serious kidney disease.
The new Randox Acusera multi-analyte Liquid Tumour Marker Control covers a total of 15 commonly tested and esoteric cancer antigens and tumour markers. The addition of assayed target values enables laboratories to effectively monitor both accuracy and precision.
Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.
A new Kaiser Permanente study found that the risk of younger siblings developing an autism spectrum disorder is 14 times higher if an older sibling has ASD. The study, which was published today in Journal of Developmental & Behavioral Pediatrics, also found the risk level was consistent across gestational age at birth.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert Jordan Lakko, DO Po Box 3648, Coeur D Alene, ID 83816-2522 Ph: (208) 292-0292 | Mr Robert Jordan Lakko, DO 1090 W Park Pl, Coeur D Alene, ID 83814-2785 Ph: (208) 292-0292 |
News Archive
Central venous catheters are commonly used to provide permanent hemodialysis for patients with serious kidney disease.
The new Randox Acusera multi-analyte Liquid Tumour Marker Control covers a total of 15 commonly tested and esoteric cancer antigens and tumour markers. The addition of assayed target values enables laboratories to effectively monitor both accuracy and precision.
Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.
A new Kaiser Permanente study found that the risk of younger siblings developing an autism spectrum disorder is 14 times higher if an older sibling has ASD. The study, which was published today in Journal of Developmental & Behavioral Pediatrics, also found the risk level was consistent across gestational age at birth.
› Verified 4 days ago
Matthew G Taylor, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 W Ironwood Dr, 320, Coeur D Alene, ID 83814 Phone: 208-625-5250 Fax: 208-625-5251 | |
Erica Magers, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 914 W Ironwood Dr Ste 101, Coeur D Alene, ID 83814 Phone: 208-625-3500 Fax: 208-625-3501 | |
Dr. Stephen Paul Smiley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1130 W Prairie Ave, Coeur D Alene, ID 83815 Phone: 208-209-0288 Fax: 208-209-0289 | |
Heidi A Herold, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7600 N Mineral Dr Ste 450b, Coeur D Alene, ID 83815 Phone: 208-209-2066 Fax: 208-209-2076 | |
Ryan John Gilles, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1919 Lincoln Way, 315, Coeur D Alene, ID 83814 Phone: 208-625-6000 Fax: 208-625-6001 | |
Dr. Matthew C. Bean, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1919 Lincoln Way Ste 315, Coeur D Alene, ID 83814 Phone: 208-625-6000 Fax: 208-625-6001 | |
Alanna Caitlin Russo, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-625-4000 |